Field | Row 1 |
---|---|
adsh | 0001824293-25-000073 |
cik | 1824293 |
name | GRI BIO, INC. |
sic | 2834 |
countryba | US |
stprba | CA |
cityba | LA JOLLA |
zipba | 92037 |
bas1 | 2223 AVENIDA DE LA PLAYA |
bas2 | SUITE 208 |
baph | (619) 400-1171 |
countryma | US |
stprma | CA |
cityma | LA JOLLA |
zipma | 92037 |
mas1 | 2223 AVENIDA DE LA PLAYA |
mas2 | SUITE 208 |
countryinc | US |
stprinc | DE |
ein | 824369909 |
former | GRI BIO, INC. |
changed | 20230424 |
afs | 4-NON |
wksi | 0 |
fye | 1231 |
form | 10-Q |
period | 20250331 |
fy | 2025 |
fp | Q1 |
filed | 20250515 |
accepted | 2025-05-15 08:39:00.0 |
prevrpt | 0 |
detail | 1 |
instance | ck0001824293-20250331_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0001824293-25-000073 | 20250331 | Accounts Payable Current | 1361000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 220000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 220000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001824293-25-000073 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -1747000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Common Stock Shares Issued | 525358.0000 | shares | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Increase Decrease In Accrued Liabilities | 562000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Liabilities And Stockholders Equity | 5739000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Net Income Loss | -1887000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001824293-25-000073 | 20240331 | Operating Expenses | 1895000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Operating Income Loss | -1895000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Operating Lease Liability Noncurrent | 71000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Prepaid Expense And Other Assets Current | 587000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Proceeds From Issuance Of Common Stock | 3605000.0000 | USD | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market Offering; | ||
0001824293-25-000073 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 525447.0000 | shares | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 37000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001824293-25-000073 | 20241231 | Cash And Cash Equivalents At Carrying Value | 5028000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 5028000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Change In Fair Value Of Warrant Liability | 2000.0000 | USD | 1 | 0001824293-25-000073 | |||
0001824293-25-000073 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
0001824293-25-000073 | 20240331 | Depreciation | 1000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Depreciation | 1000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Earnings Per Share Diluted | -5.8000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Increase Decrease In Accounts Payable | 331000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Increase Decrease In Operating Lease Liability | -14000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Liabilities | 1707000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Liabilities | 2837000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Liabilities Current | 1636000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Net Income Loss | -1887000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Net Income Loss | -3046000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001824293-25-000073 | 20250331 | Operating Income Loss | -3051000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Operating Lease Liability Current | 48000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Proceeds From Issuance Of Common Stock | 0.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= Through Financing; | ||
0001824293-25-000073 | 20250331 | Property Plant And Equipment Net | 3000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Stockholders Equity | 2798000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Stockholders Equity | -33420000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001824293-25-000073 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001824293-25-000073 | 20240331 | Stock Issued During Period Shares Warrant Exercise | 10047.0000 | shares | 1 | 0001824293-25-000073 | Equity Components= Common Stock; | ||
0001824293-25-000073 | 20240331 | Stock Issued During Period Value New Issues | 4389000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Stock Issued During Period Value New Issues | 4389000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001824293-25-000073 | 20241231 | Assets | 5739000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Accounts Payable Current | 897000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 4091000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 3281000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Common Stock Shares Issued | 525485.0000 | shares | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Earnings Per Share Basic | -101.0500 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 14000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Payment For Fractional Shares Reverse Stock Split | 1000.0000 | USD | 1 | 0001824293-25-000073 | |||
0001824293-25-000073 | 20240331 | Research And Development Expense | 933000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Retained Earnings Accumulated Deficit | -42786000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Share Based Compensation | 220000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001824293-25-000073 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001824293-25-000073 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 18665.0000 | shares | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 37000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Assets Current | 5615000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20231231 | Common Stock Shares Outstanding | 2909.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001824293-25-000073 | 20241231 | Common Stock Value Outstanding | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | General And Administrative Expense | 1411000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Liabilities And Stockholders Equity | 4042000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Net Cash Provided By Used In Operating Activities | -1736000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Proceeds From Issuance Of Common Stock | 5500000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= Through Financing; | ||
0001824293-25-000073 | 20250331 | Proceeds From Issuance Of Common Stock | 3605000.0000 | USD | 3 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market Offering; | ||
0001824293-25-000073 | 20241231 | Property Plant And Equipment Net | 4000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Retained Earnings Accumulated Deficit | -39740000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Stock Issued During Period Value Fractional Share Adjustment | 1000.0000 | USD | 1 | 0001824293-25-000073 | |||
0001824293-25-000073 | 20250331 | Stock Issued During Period Value Fractional Share Adjustment | 1000.0000 | USD | 1 | 0001824293-25-000073 | Equity Components= Additional Paid In Capital; | ||
0001824293-25-000073 | 20250331 | Accrued Liabilities Current | 1368000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Assets | 4042000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Change In Fair Value Of Warrant Liability | 0.0000 | USD | 1 | 0001824293-25-000073 | |||
0001824293-25-000073 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
0001824293-25-000073 | 20240331 | General And Administrative Expense | 962000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Increase Decrease In Operating Lease Liability | -11000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Net Cash Provided By Used In Financing Activities | -11000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Operating Lease Right Of Use Asset | 109000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Payments Of Stock Issuance Costs | 10000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Recognition Of Right Of Use Assets And Lease Liabilities | 152000.0000 | USD | 1 | 0001824293-25-000073 | |||
0001824293-25-000073 | 20250331 | Research And Development Expense | 1640000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Share Based Compensation | 37000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20231231 | Stockholders Equity | 259000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20231231 | Stockholders Equity | 31792000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001824293-25-000073 | 20240331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001824293-25-000073 | 20241231 | Stockholders Equity | 4032000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Stockholders Equity | -42786000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001824293-25-000073 | 20240331 | Stock Issued During Period Shares New Issues | 1495.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001824293-25-000073 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 525447.0000 | shares | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 18665.0000 | shares | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Common Stock Shares Outstanding | 525485.0000 | shares | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Fair Value Adjustment Of Warrants | -2000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Net Cash Provided By Used In Financing Activities | 4486000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Operating Lease Right Of Use Asset | 120000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Payment For Fractional Shares Reverse Stock Split | 0.0000 | USD | 1 | 0001824293-25-000073 | |||
0001824293-25-000073 | 20250331 | Prepaid Expense And Other Assets Current | 649000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Recognition Of Right Of Use Assets And Lease Liabilities | 0.0000 | USD | 1 | 0001824293-25-000073 | |||
0001824293-25-000073 | 20250331 | Stockholders Equity | 1205000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Stockholders Equity | 43991000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001824293-25-000073 | 20240331 | Stock Issued During Period Shares Fractional Share Adjustment | 1.0000 | shares | 1 | 0001824293-25-000073 | Equity Components= Common Stock; | ||
0001824293-25-000073 | 20241231 | Additional Paid In Capital Common Stock | 43772000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Assets Current | 3930000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Cash And Cash Equivalents At Carrying Value | 3281000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1808000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 2283000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Common Stock Shares Authorized | 250000000.0000 | shares | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Common Stock Shares Outstanding | 525358.0000 | shares | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Common Stock Value Outstanding | 0.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid | 97000.0000 | USD | 1 | 0001824293-25-000073 | |||
0001824293-25-000073 | 20240331 | Earnings Per Share Diluted | -101.0500 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Fair Value Adjustment Of Warrants | 0.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Increase Decrease In Accounts Payable | -744000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -564000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -196000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Interest Income Expense Nonoperating Net | 6000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Liabilities Current | 2779000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Net Cash Provided By Used In Operating Activities | -2203000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Operating Expenses | 3051000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Operating Lease Liability Current | 50000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Payments Of Stock Issuance Costs | 1014000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250430 | Proceeds From Issuance Of Common Stock | 399000.0000 | USD | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; Subsidiary Sale Of Stock= At The Market Offering; | ||
0001824293-25-000073 | 20240331 | Stockholders Equity | 36218000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001824293-25-000073 | 20241231 | Stockholders Equity | 43772000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0001824293-25-000073 | 20241231 | Stockholders Equity | -39740000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0001824293-25-000073 | 20250331 | Stock Issued During Period Shares Fractional Share Adjustment | 127.0000 | shares | 1 | 0001824293-25-000073 | Equity Components= Common Stock; | ||
0001824293-25-000073 | 20241231 | Accrued Liabilities Current | 691000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Additional Paid In Capital Common Stock | 43991000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20241231 | Common Stock Shares Authorized | 250000000.0000 | shares | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Common Stock Shares Outstanding | 14450.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001824293-25-000073 | 20241231 | Common Stock Shares Outstanding | 525485.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001824293-25-000073 | 20250331 | Common Stock Shares Outstanding | 525358.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0001824293-25-000073 | 20250331 | Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid | 247000.0000 | USD | 1 | 0001824293-25-000073 | |||
0001824293-25-000073 | 20250331 | Earnings Per Share Basic | -5.8000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20240331 | Increase Decrease In Accrued Liabilities | -172000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Interest Income Expense Nonoperating Net | 5000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Net Income Loss | -3046000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Operating Lease Liability Noncurrent | 58000.0000 | USD | 0 | us-gaap/2024 | |||
0001824293-25-000073 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 11000.0000 | USD | 1 | us-gaap/2024 | |||
0001824293-25-000073 | 20231231 | Stockholders Equity | -31533000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
Interest Income Expense Nonoperating Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income (Expense), Nonoperating | Amount of interest income (expense) classified as nonoperating. |
Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Stock Issued During Period Shares Warrant Exercise | 0001824293-25-000073 | 1 | 0 | shares | D | Stock Issued During Period, Shares, Warrant Exercise | Stock Issued During Period, Shares, Warrant Exercise | |
Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Stock Issued During Period Shares Fractional Share Adjustment | 0001824293-25-000073 | 1 | 0 | shares | D | Stock Issued During Period, Shares, Fractional Share Adjustment | Stock Issued During Period, Shares, Fractional Share Adjustment | |
Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
Change In Fair Value Of Warrant Liability | 0001824293-25-000073 | 1 | 0 | monetary | D | C | Change In Fair Value Of Warrant Liability | Change In Fair Value Of Warrant Liability |
Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid | 0001824293-25-000073 | 1 | 0 | monetary | D | C | Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid | Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid |
Payments Of Stock Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
Payment For Fractional Shares Reverse Stock Split | 0001824293-25-000073 | 1 | 0 | monetary | D | C | Payment For Fractional Shares, Reverse Stock Split | Payment For Fractional Shares, Reverse Stock Split |
Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
Stock Issued During Period Value Fractional Share Adjustment | 0001824293-25-000073 | 1 | 0 | monetary | D | D | Stock Issued During Period, Value, Fractional Share Adjustment | Stock Issued During Period, Value, Fractional Share Adjustment |
Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Fair Value Adjustment Of Warrants | us-gaap/2024 | 0 | 0 | monetary | D | D | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. |
Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
Common Stock Value Outstanding | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Outstanding | Value of common shares held by shareholders. Excludes common shares repurchased and held as treasury shares. |
Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
Recognition Of Right Of Use Assets And Lease Liabilities | 0001824293-25-000073 | 1 | 0 | monetary | D | D | Recognition Of Right Of Use Assets And Lease Liabilities | Recognition Of Right Of Use Assets And Lease Liabilities |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0001824293-25-000073 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
0001824293-25-000073 | 2 | 4 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
0001824293-25-000073 | 2 | 5 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
0001824293-25-000073 | 2 | 6 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
0001824293-25-000073 | 2 | 7 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
0001824293-25-000073 | 2 | 8 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
0001824293-25-000073 | 2 | 11 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
0001824293-25-000073 | 2 | 12 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
0001824293-25-000073 | 2 | 13 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liabilities, current | 0 |
0001824293-25-000073 | 2 | 14 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
0001824293-25-000073 | 2 | 15 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liabilities, non-current | 0 |
0001824293-25-000073 | 2 | 16 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
0001824293-25-000073 | 2 | 17 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 9) | 0 |
0001824293-25-000073 | 2 | 19 | BS | 0 | H | Common Stock Value Outstanding | us-gaap/2024 | Common stock, 0.0001 par value; 250,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 525,358 and 525,485 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 0 |
0001824293-25-000073 | 2 | 20 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
0001824293-25-000073 | 2 | 21 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
0001824293-25-000073 | 2 | 22 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity | 0 |
0001824293-25-000073 | 2 | 23 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
0001824293-25-000073 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in usd per share) | 0 |
0001824293-25-000073 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized (in shares) | 0 |
0001824293-25-000073 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued (in shares) | 0 |
0001824293-25-000073 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding (in shares) | 0 |
0001824293-25-000073 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
0001824293-25-000073 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
0001824293-25-000073 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
0001824293-25-000073 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
0001824293-25-000073 | 4 | 6 | IS | 0 | H | Change In Fair Value Of Warrant Liability | 0001824293-25-000073 | Change in fair value of warrant liability | 0 |
0001824293-25-000073 | 4 | 7 | IS | 0 | H | Interest Income Expense Nonoperating Net | us-gaap/2024 | Interest income | 0 |
0001824293-25-000073 | 4 | 8 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001824293-25-000073 | 4 | 9 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share of common stock, basic (in usd per share) | 0 |
0001824293-25-000073 | 4 | 10 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share of common stock, diluted (in usd per share) | 0 |
0001824293-25-000073 | 4 | 11 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted-average common shares outstanding, basic (in shares) | 0 |
0001824293-25-000073 | 4 | 12 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted-average common shares outstanding, diluted (in shares) | 0 |
0001824293-25-000073 | 5 | 9 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Beginning balance (in shares) | 0 |
0001824293-25-000073 | 5 | 10 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
0001824293-25-000073 | 5 | 11 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
0001824293-25-000073 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares Fractional Share Adjustment | 0001824293-25-000073 | Fractional share adjustment (in shares) | 1 |
0001824293-25-000073 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Value Fractional Share Adjustment | 0001824293-25-000073 | Fractional share adjustment | 1 |
0001824293-25-000073 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock and prefunded warrants in financing (in shares) | 0 |
0001824293-25-000073 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common stock and prefunded warrants in financing | 0 |
0001824293-25-000073 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Shares Warrant Exercise | 0001824293-25-000073 | Prefunded warrant exercise (in shares) | 0 |
0001824293-25-000073 | 5 | 17 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001824293-25-000073 | 5 | 18 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ending balance (in shares) | 0 |
0001824293-25-000073 | 5 | 19 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
0001824293-25-000073 | 6 | 7 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0001824293-25-000073 | 6 | 9 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation expense | 0 |
0001824293-25-000073 | 6 | 10 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation expense | 0 |
0001824293-25-000073 | 6 | 11 | CF | 0 | H | Fair Value Adjustment Of Warrants | us-gaap/2024 | Change in fair value of warrant liability | 0 |
0001824293-25-000073 | 6 | 12 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | Change in operating lease right-of-use assets | 0 |
0001824293-25-000073 | 6 | 14 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
0001824293-25-000073 | 6 | 15 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
0001824293-25-000073 | 6 | 16 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses | 0 |
0001824293-25-000073 | 6 | 17 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liabilities | 0 |
0001824293-25-000073 | 6 | 18 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Cash used in operating activities | 0 |
0001824293-25-000073 | 6 | 20 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from issuance of common stock in financing transactions | 0 |
0001824293-25-000073 | 6 | 21 | CF | 0 | H | Payment For Fractional Shares Reverse Stock Split | 0001824293-25-000073 | Payment for fractional shares in connection with reverse stock split | 1 |
0001824293-25-000073 | 6 | 22 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Payment of deferred stock issuance costs | 1 |
0001824293-25-000073 | 6 | 23 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Cash (used in) provided by financing activities | 0 |
0001824293-25-000073 | 6 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net (decrease) increase in cash and cash equivalents | 0 |
0001824293-25-000073 | 6 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
0001824293-25-000073 | 6 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
0001824293-25-000073 | 6 | 28 | CF | 0 | H | Recognition Of Right Of Use Assets And Lease Liabilities | 0001824293-25-000073 | Recognition of right-of-use assets and lease liabilities | 0 |
0001824293-25-000073 | 6 | 29 | CF | 0 | H | Debt Issuance Costs And Financing Costs Incurred But Not Yet Paid | 0001824293-25-000073 | Deferred stock issuance costs in accounts payable and accrued expenses | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |